AR and hepatocellular carcinoma: However, the characterization of which AR-SVs are key drivers in HCC, the determination of the presence of any HCC specific variants, and the assessment of the AR variant makeup of HCC patients are key steps to further understand the role of AR-SVs in HCC as compared to PCa.